Print

Cardium Therapeutics, Inc. (CXM) Reports on Second Quarter 2013 Financial Results and Recent Business Developments  
8/14/2013 7:22:19 AM

Regeneron may be hiring! Check it out! (Isn't it tempting?)

SAN DIEGO, Aug. 14, 2013 /PRNewswire/ -- Cardium Therapeutics (NYSE MKT: CXM) today presented its financial results for the second quarter ended June 30, 2013, and reported on recent highlights and other business developments including:

-- Distribution agreement with AvKARE Inc. for the sale and distribution of Excellagen into government medical facilities throughout the United States.

Help employers find you! Check out all the jobs and post your resume.

//-->